Related Experiment Video
Updated: Apr 6, 2026
09:28
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Published on: February 2, 2013
15.7K
High-Throughput Cytotoxicity Testing System of Acetaminophen Using a Microfluidic Device (MFD) in HepG2 Cells
Seon Min Ju1, Hyun-Jun Jang2, Kyu-Bong Kim2
1a Department of Biomedical Science , Dankook University Graduate School, Dankook University , Cheonan , Chungnam , Republic of Korea.
Journal of Toxicology and Environmental Health. Part A
|August 5, 2015
Summary
This study introduces a microfluidic device for high-throughput drug screening, enabling rapid and efficient cytotoxicity testing with minimal reagent use. The lab-on-a-chip system provides comparable results to traditional methods, suggesting its potential for new drug development.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Toxicology
Background:
- Lab-on-a-chip (LOC) devices offer advantages like low sample consumption and faster analysis.
- Microfluidic devices enable high-throughput drug screening (HTDS) for cytotoxicity assessment.
- HepG2 cells are a standard model for liver toxicity studies.
Purpose of the Study:
- To develop and validate a microfluidic high-throughput cytotoxicity device (μHTCD) for drug screening.
- To assess the efficacy of the μHTCD in generating concentration-dependent cytotoxicity data.
- To compare the performance of the μHTCD with traditional 96-well culture systems.
Main Methods:
- A microfluidic device with an array of eight microchambers was designed.
- HepG2 cells were cultured and exposed to varying concentrations of acetaminophen (APAP) using a gradient generator.
- Cytotoxicity was assessed across 32 experimental results generated from a single chip.
Main Results:
- The μHTCD generated progressive, concentration-dependent cytotoxicity results for APAP.
- The μHTCD demonstrated comparable cytotoxicity data to the 96-well culture system.
- The system required minimal reagent volumes and reduced experimental time.
Conclusions:
- The developed HTDS system is effective for cytotoxicity screening.
- The μHTCD offers a viable alternative to conventional methods for drug development.
- This microfluidic approach can be applied to diverse cell types for broader screening applications.
